TrialEuropean heart journal2025

Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial.

Manan Pareek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.